Chimin Health Management Co Ltd
603222
Company Profile
Business description
Chimin Health Management Co Ltd is engaged in the pharmaceutical industry. It is engaged in the research and development, production and sales of human medicines and medical devices. Its product centers include large volume injection, medical instruments, Nephrology treatment, and medical service. The company has production bases in Taizhou, Shanghai and Spain.
Contact
No. 888, Beiyuan Road
Huangyan District, Zhejiang Province
Taizhou318020
CHNT: +86 57684066800
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
1,890
Stocks News & Analysis
stocks
ASX miner weathers the storm with strong commodity prices
Lower volumes due cyclone activity but revenues hold steady.
stocks
Eli Lilly earnings: Mounjaro/Zepbound’s massive volume growth more than counters price pressure
We’ve raised our fair value estimate of Lilly stock.
stocks
OpenAI missed multiple revenue targets - here’s why it likely won’t IPO this year
Plus, whichever AI company IPOs first defines what “good” looks like.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,970.10 | 5.80 | -0.06% |
| CAC 40 | 8,114.84 | 0.00 | 0.00% |
| DAX 40 | 24,292.38 | 337.82 | 1.41% |
| Dow JONES (US) | 49,652.14 | 790.33 | 1.62% |
| FTSE 100 | 10,378.82 | 165.71 | 1.62% |
| HKSE | 25,776.53 | 335.31 | -1.28% |
| NASDAQ | 24,892.31 | 219.07 | 0.89% |
| Nikkei 225 | 59,670.52 | 385.60 | 0.65% |
| NZX 50 Index | 13,039.20 | 135.89 | 1.05% |
| S&P 500 | 7,209.01 | 73.06 | 1.02% |
| S&P/ASX 200 | 8,746.30 | 4.70 | -0.05% |
| SSE Composite Index | 4,112.16 | 4.65 | 0.11% |